Mind Over Cancer is a charity that supports the mental health and wellbeing of the whole family living with a cancer diagnosis between the ages of 0–29 years, with services that they can access at any time of life. Why? Because a cancer diagnosis doesn’t disappear when treatment stops.
When a child, teenager or young adult is diagnosed with cancer it affects the whole family. There isn’t a guidebook on how to get through it and everyone will cope with it in their own way.
Mind Over Cancer offers two services, the first being the funding of up to 10 counselling sessions, matching each client to the most appropriate counsellor for their needs. We aim to have them in their first counselling session in 2-3 weeks of receiving their referral.
The second service is an on-line support programme for people to meet others with a shared experience, groups include young people with the cancer diagnosis, siblings, parents, and friends.
A cancer diagnosis can bring different thoughts and feelings at different stages of a person’s life both during and after treatment. This is normal and for families who are living with the diagnosis it is just as important for them to look after their mental health as it is their physical health.
Talking about these thoughts and feelings when a person is ready to is very important …for many this could be years after treatment ends.
Help us to make cancer and mental health an everyday conversation.
https://www.mindovercancer.org.uk
When a child, teenager or young adult is diagnosed with cancer it affects the whole family. There isn’t a guidebook on how to get through it and everyone will cope with it in their own way.
Mind Over Cancer offers two services, the first being the funding of up to 10 counselling sessions, matching each client to the most appropriate counsellor for their needs. We aim to have them in their first counselling session in 2-3 weeks of receiving their referral.
The second service is an on-line support programme for people to meet others with a shared experience, groups include young people with the cancer diagnosis, siblings, parents, and friends.
A cancer diagnosis can bring different thoughts and feelings at different stages of a person’s life both during and after treatment. This is normal and for families who are living with the diagnosis it is just as important for them to look after their mental health as it is their physical health.
Talking about these thoughts and feelings when a person is ready to is very important …for many this could be years after treatment ends.
Help us to make cancer and mental health an everyday conversation.
https://www.mindovercancer.org.uk
Mission Street have established a market-leading and rapidly growing Science and Innovation platform.
The current portfolio comprises over 1.5 million sq ft of committed projects in key strategic locations within Oxford, Cambridge and Bristol. Our innovative schemes and campuses are being developed speculatively with the first phases being the next available lab space in the respective locations.
Mission Street was founded in 2017 as an independent investor, developer and operator of Science and Innovation real estate. The company has since established itself as an industry leader working in conjunction with a highly experienced Advisory Board who bring invaluable insight and expertise from the perspective of our customers.
The current portfolio comprises over 1.5 million sq ft of committed projects in key strategic locations within Oxford, Cambridge and Bristol. Our innovative schemes and campuses are being developed speculatively with the first phases being the next available lab space in the respective locations.
Mission Street was founded in 2017 as an independent investor, developer and operator of Science and Innovation real estate. The company has since established itself as an industry leader working in conjunction with a highly experienced Advisory Board who bring invaluable insight and expertise from the perspective of our customers.
Drug Discovery
Clinical stage drug development company, bringing a stratified approach to neuroscience drug repurposing using digital biomarkers
Mursla is a startup developing a diagnostic device that leverages proprietary nanostructures to significantly improve cancer detection through the utilization of a novel, non-invasive procedure called liquid biopsy.
My Green Lab’s mission is to build a global culture of sustainability in science and is a world leader in developing environmental standards for laboratories and laboratory products—bringing sustainability solutions to the community responsible for the world’s life-changing medical innovations.
The importance of this effort cannot be overlooked - Laboratories are some of the most resource-intensive buildings of any kind. A typical laboratory can use up to 10x more energy and 4x more water than a typical office building. Additionally, laboratory supply chains are responsible for approximately 2% of worldwide plastic waste, making the scientific community’s efforts to reduce its environmental impact a truly global effort. My Green Lab estimates there are over 265,000 labs worldwide and over 2,000,000 laboratory products, each providing an opportunity for My Green Lab programs and services in an increasingly environmentally conscious and cost-sensitive industry.
As such, My Green Lab’s two flagship programs, Green Lab Certification and ACT Label are designed to address the environmental impact in laboratories and lab supply chains respectively. Each certification program delivers customer value by proving frameworks for scientific organizations to reduce environmental impact, realize cost savings, and create market differentiation for their scientific organizations and/or products.
Since the development of the My Green Lab Certification and ACT Label, My Green Lab as an organization has grown from a grassroots effort to the most influential organization in the laboratory sustainability space. My Green Lab counts 23 of 25 of the world’s largest pharma companies as customers, with more than 1,300 labs and 2,400 products certified across 220 organizations and in 39 countries. With proven market fit, its recent endorsement by the United Nations Race to Zero Program, and a substantial lead on the competition, My Green Lab is positioned for global growth.
The importance of this effort cannot be overlooked - Laboratories are some of the most resource-intensive buildings of any kind. A typical laboratory can use up to 10x more energy and 4x more water than a typical office building. Additionally, laboratory supply chains are responsible for approximately 2% of worldwide plastic waste, making the scientific community’s efforts to reduce its environmental impact a truly global effort. My Green Lab estimates there are over 265,000 labs worldwide and over 2,000,000 laboratory products, each providing an opportunity for My Green Lab programs and services in an increasingly environmentally conscious and cost-sensitive industry.
As such, My Green Lab’s two flagship programs, Green Lab Certification and ACT Label are designed to address the environmental impact in laboratories and lab supply chains respectively. Each certification program delivers customer value by proving frameworks for scientific organizations to reduce environmental impact, realize cost savings, and create market differentiation for their scientific organizations and/or products.
Since the development of the My Green Lab Certification and ACT Label, My Green Lab as an organization has grown from a grassroots effort to the most influential organization in the laboratory sustainability space. My Green Lab counts 23 of 25 of the world’s largest pharma companies as customers, with more than 1,300 labs and 2,400 products certified across 220 organizations and in 39 countries. With proven market fit, its recent endorsement by the United Nations Race to Zero Program, and a substantial lead on the competition, My Green Lab is positioned for global growth.
No data available
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick Science Park. We are using synthetic biology approaches to develop a completely novel modality for the targeted, intracellular delivery of therapeutic proteins and peptides.
No data available
NEB UK supplies a broad range of reagents and kits for basic and applied research at the DNA, RNA and protein levels. These products are also for use in drug development and screening, as well as for use in platform technologies and as raw materials in kit manufacture. We supply standard catalogue products as well as custom and bulk formulations. We would like to partner with you from R&D downstream to market. Call us to discuss your ‘biological component’ needs.